Drug archive
Lamivudine and Zidovudine (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antiviral (systemic)
Description
Lamivudine (la-MI-vyoo-deen) and zidovudine (zye-DOE-vyoo-deen) combination is used in the treatment of human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS).
Lamivudine and zidovudine combination will not cure or prevent HIV infection or the symptoms of AIDS; however, it helps keep HIV from reproducing, and appears to slow down the destruction of the immune system. This may help delay the development of serious health problems usually related to AIDS or HIV infection. Lamivudine and zidovudine combination will not keep you from spreading HIV to other people. People who receive this medicine may continue to have other problems usually related to AIDS or HIV infection.
The zidovudine component of this combination medicine may cause some serious side effects, including bone marrow problems. Symptoms of bone marrow problems include fever, chills, sore throat, pale skin, and unusual tiredness or weakness. These problems may require blood transfusion or temporarily stopping treatment with lamivudine and zidovudine combination. Check with your doctor if any new health problems or symptoms occur while you are taking lamivudine and zidovudine combination.
This medicine is available only with your doctor's prescription, in the following dosage form:
- Tablets (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Combivir
† Not commercially available in Canada.